Genenta
1 known investors
Genenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.
Founders & leadership
PP
Investors · 1
Competitors · 5
by search overlap
Tsenta18 shared keywordsTsenta automates job applications by monitoring 50,000+ career pages across major applicant tracking systems and submitting tailored, ATS-optimized applications within minutes of job postings. The platform serves active job seekers seeking to increase application volume and speed while maintaining quality application materials.
Ejenta16 shared keywordsEjenta builds an agentic AI platform for connected care that delivers intelligent healthcare solutions to patient homes and manages care for members with chronic conditions like heart failure. The company partners with health plans and healthcare organizations to enable remote monitoring and intelligent care delivery.
Enanta Pharmaceuticals13 shared keywordsEnanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).
Zentalis10 shared keywordsZentalis is a clinical-stage pharmaceutical company developing azenosertib, an investigational oral therapy that inhibits WEE1 kinase to disrupt the cell-cycle safeguards cancer cells use to survive. It focuses on providing physicians and patients with a targeted, non-chemotherapy oral treatment option in oncology.
LeadIQ9 shared keywordsLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.
Companies competing with Genenta for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Genenta do?
- Genenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.
- Who founded Genenta?
- Genenta was founded by Pierluigi Paracchi.
- Who are Genenta's investors?
- Genenta's investors include CDP Venture Capital.